Kenvue Inc.(KVUE)Company Profile & BusinessNYSE
Business, leadership and ownership
Company Profile
Business overview, scale, and footprint
Business Overview
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Transactions
Open-market activity and option exercises
Insider Activity Summary
Insider trading activity for Kenvue Inc. (KVUE) between Nov 29, 2024 and Sep 25, 2026 consists of 71 total transactions. Among these, company executives and board members conducted 69 buys (totaling 7,481,111 shares) and 2 sells (totaling 42,191.296 shares). This activity resulted in a net change of 7,438,919.704 shares, reflecting net buying interest with an estimated net acquisitions value of $707.25M.
71 insider transactions found. Showing 10 of 71 transactions.
| Insider Name | Relation to Company | Shares Changed | Price | Transaction Date |
|---|---|---|---|---|
| STEVENS MEREDITH | Chief Operating Officer | 1,461 | N/A | Sep 25, 2026 |
| DASGUPTA ANINDYA | Officer | 16,418 | N/A | Jul 31, 2026 |
| HOWLETT HEATHER | Chief Financial Officer | 3,700 | $0.07 | Jun 10, 2026 |
| Howlett Heather | CFO & CAO | -3,700 | $18.11 | Jun 10, 2026 |
| ORLANDO MATTHEW | General Counsel | 38,491 | $0.68 | May 8, 2026 |
| Orlando Matthew | General Counsel | -38,491.296 | $17.66 | May 8, 2026 |
| CURADO GOMES DE LEMOS LEONARDO | Officer | 24,247 | N/A | May 1, 2026 |
| STEVENS MEREDITH | Chief Operating Officer | 5,169 | N/A | Mar 10, 2026 |
| ALVARADO LUANI | Chief Operating Officer | 4,222 | N/A | Mar 10, 2026 |
| LAWSON CARLTON | Officer | 6,157 | N/A | Mar 10, 2026 |
Explore More Analysis for KVUE
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.